Companies: 10,795·Total market cap: $144.5T
Boston Scientific Corporation

Boston Scientific Corporation

BSXNYSEHealthcare● Active
$48.69
+$0.14(+0.29%)
Market Cap$72.4B
P/E Ratio
52W High$109.5
52W Low$47.17
Overview

Boston Scientific Corporation (BSX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

bsx · stock forecast · 44 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 44 Wall Street analysts in the past 3 months

SellBuy

Buy

44 analysts

consensus

Rating Breakdown

Strong Buy
1
Buy
38
Hold
5
Sell
0
Strong Sell
0
Total: 44 · Buy rate: 88.6%

12-Month Price Target

High

$120

Consensus

$83.84

+72.1% upside

Low

$55.00

Median: $77 · Last Close: $48.70

The Boston Scientific Corporation (BSX) analyst consensus is Buy, based on ratings from 44 Wall Street analysts over the past 3 months. The average 12-month BSX price target is $83.84, representing +72.1% upside from the current price of $48.70.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $84 (72.1%)

Consensus Target

$83.84

72.1% upside

High Target

$120

146.4%

Low Target

$55

12.9%

Current Price

$48.70

as of today

Based on analyst price targets, the BSX stock price prediction for the next 12 months ranges from $55 to $120. The consensus BSX price forecast of $83.84 implies 72.1% upside from the current price of $48.70.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$46.275.00%

1-day model range: $45.94–$46.6. Peak: $46.6 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$60+23.9%
2028$70+43.2%
2029$77+57.7%
2030$82+68.0%
2031+75.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%0%86%
2Buy
0Neutral
12Sell
RSI (14)24.0Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · BSX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$48.29BUY
MA 10$49.50SELL
MA 20$52.30SELL
MA 50$57.54SELL
MA 100$67.90SELL
MA 200$83.56SELL
Current $BSX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$48.73SELL
EMA 10$49.80SELL
EMA 20$51.98SELL
EMA 50$57.82SELL
EMA 100$66.50SELL
EMA 200$76.91SELL
Current $BSX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Truist Securities2026-06-04
Maintains
BuyBuy
BTIG2026-06-03
Maintains
BuyBuy
Canaccord Genuity2026-06-01
Maintains
BuyBuy
Wolfe Research2026-05-29
Downgrade ↓
OutperformPeer Perform
Barclays2026-05-28
Maintains
OverweightOverweight
Citigroup2026-05-28
Maintains
BuyBuy
Leerink Partners2026-05-28
Maintains
OutperformOutperform
Wells Fargo2026-05-28
Downgrade ↓
OverweightEqual Weight
Baird2026-05-19
Maintains
OutperformOutperform
B of A Securities2026-05-18
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Boston Scientific Corporation (BSX) stock. Of the recent 416 rating actions, 34 were upgrades and 14 were downgrades. 44 analysts currently cover BSX.

Analyst Recommendation Trends

Buy ratings13↑ +2
Hold ratings00
Sell ratings00

BSX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$21.6B

↓ 14.4% YoY

Revenue Next Year

$23.4B

↑ 8.0% YoY

EPS This Year

$3.37

EPS Next Year

$3.73

↑ 10.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BSX EPS of $3.37 for the current fiscal year, based on estimates from 17 analysts. The BSX revenue forecast is $21.6B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The BSX stock forecast is supported by two independent data sources: analyst consensus ratings from 44 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BSX price target is $83.84 (+72.1% upside), with an analyst consensus of Buy.

The BSX short-term stock prediction for tomorrow is $46.27 (-5.00%). The BSX stock price prediction for 2027 estimates an average of $60. The BSX stock prediction for 2030 projects a range of $77–$87.

Boston Scientific Corporation trades on NYSE under the ticker BSX. The BSX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 89% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

BSX forecast · 8 questions

According to 44 Wall Street analysts, the average 12-month BSX price target is $83.84, with a high forecast of $120.00 and a low of $55.00. The median price target is shown in the chart above when available. This implies +72.1% potential upside from the current price of $48.70.

BSX price targetWhat is BSX price targetBSX analyst price targetBSX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.